Quetiapine Is Not Associated with Increase in Prolactin Secretion in Contrast to Haloperidol

Selmanoff, 1981, The lateral and medial median eminence, Endocrinology, 108, 1716, 10.1210/endo-108-5-1716

Dickson, 1999, Neuroleptic-induced hyperprolactinemia, Schizophr Res, 35, S75, 10.1016/S0920-9964(98)00159-5

Casey, 1996, Side effect profiles of new antipsychotic agents, J Clin Psychiatry, 57, S40

Bymaster, 1997, In vitro and in vivo biochemistry of olanzapine, J Clin Psychiatry, 58, S28

Kane, 1981, Clozapine, Psychopharmacology, 73, 184, 10.1007/BF00429215

Lee, 1995, Clozapine does not elevate serum prolactin levels in healthy men, Biol Psychiatry, 38, 762, 10.1016/0006-3223(95)00366-5

Bowden, 1992, Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro, J Pharmacol Exp Ther, 262, 699

Breier, 1999, Clozapine and risperidone in chronic schizophrenia, Am J Psychiatry, 156, 294, 10.1176/ajp.156.2.294

Dickson, 1995, Risperidone induced prolactin elevations in premenopausal women with schizophrenia, Am J Psychiatry, 152, 1102, 10.1176/ajp.152.7.1102b

Arvanitis, 1997, Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia, Biol Psychiatry, 42, 233, 10.1016/S0006-3223(97)00190-X

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C., USA. American Psychiatric Association;1994.

Overall, 1962, Brief psychiatric rating scale, Psychol Rep, 10, 799, 10.2466/pr0.1962.10.3.799

Andreasen NC. Scale for the assessment of negative symptoms (SANS). Department of Psychiatry College of Medicine. The University of Iowa, Ames, IA, USA; 1983.

Andreasen NC. Scale for the assessment of positive symptoms (SAPS). Department of Psychiatry College of Medicine. The University of Iowa, Ames, IA, USA; 1984.

Chouinard, 1980, The extrapyramidal symptom rating scale, Can J Neurol Sci, 7, 233

Kuruvilla, 1992, A study of serum prolactin levels in schizophrenia, Clin Exp Pharmacol Physiol, 19, 603, 10.1111/j.1440-1681.1992.tb00511.x

Crawford, 1997, The acute and long-term effects of olanzapine compared with placebo and haloperidol on serum prolactin concentrations, Schizophr Res, 26, 41, 10.1016/S0920-9964(97)00036-4

Tran, 1997, Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders, J Clin Psychopharmacol, 17, 407, 10.1097/00004714-199710000-00010

Emsley, 2000, Comparison of the effects of quetiapine (seroquel) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment, Int Clin Psychopharmacol, 15, 121, 10.1097/00004850-200015030-00001

Petty, 1999, Prolactin and antipsychotic medications, Schizophr Res, 35, S67, 10.1016/S0920-9964(98)00158-3

Kapur, 1998, 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia, Am J Psychiatry, 155, 921, 10.1176/ajp.155.7.921

Lavalaye, 1999, Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia, Psychiatry Res, 92, 33, 10.1016/S0925-4927(99)00032-3

Owens, 1994, Extrapyramidal side effects and tolerability of risperidone, J Clin Psychiatry, 55, S29

Peuskens, 1995, Risperidone in the treatment of patients with chronic schizophrenia, Br J Psychiatry, 66, 712, 10.1192/bjp.166.6.712

Kapur, 2000, A positron emission tomography study of quetiapine in schizophrenia, Arch Gen Psychiatry, 57, 553, 10.1001/archpsyc.57.6.553

Kufferle, 1997, IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol, Psychopharmacology, 33, 323, 10.1007/s002130050409

Kasper, 1999, Dopamine and serotonin-receptors in schizophrenia, Aur Arch Psychiatry Clin Neurosci, 249, S83, 10.1007/PL00014189